| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
130,358 |
107,437 |
$3.81M |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
10,213 |
8,780 |
$762K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
14,599 |
12,276 |
$701K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
11,914 |
10,130 |
$562K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
19,245 |
16,064 |
$447K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
29,600 |
23,386 |
$422K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
3,893 |
3,551 |
$413K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
7,172 |
6,454 |
$348K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
7,738 |
5,821 |
$285K |
| 99222 |
Initial hospital care, per day, moderate complexity |
5,477 |
3,703 |
$277K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,871 |
3,315 |
$183K |
| 99460 |
|
1,577 |
1,349 |
$136K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
12,757 |
6,530 |
$105K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
822 |
631 |
$104K |
| 20610 |
|
2,817 |
2,238 |
$95K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,829 |
1,594 |
$90K |
| 90670 |
|
7,831 |
7,383 |
$82K |
| 59400 |
Routine obstetric care including antepartum care, vaginal delivery, and postpartum care |
143 |
91 |
$80K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
14,042 |
8,663 |
$79K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
5,057 |
3,321 |
$77K |
| 99223 |
Prolong inpt eval add15 m |
801 |
667 |
$73K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
1,929 |
939 |
$72K |
| 90698 |
|
6,155 |
5,840 |
$71K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
1,706 |
1,553 |
$69K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
7,170 |
5,188 |
$63K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,516 |
1,438 |
$57K |
| 90680 |
|
5,423 |
5,097 |
$57K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,154 |
877 |
$56K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
4,669 |
2,119 |
$49K |
| 90633 |
|
3,107 |
2,913 |
$32K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
5,335 |
4,733 |
$31K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
835 |
735 |
$30K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
833 |
733 |
$30K |
| 90744 |
|
2,802 |
2,638 |
$29K |
| 90688 |
|
2,630 |
2,360 |
$29K |
| 90710 |
|
2,054 |
1,936 |
$23K |
| 99306 |
Prolong nursin fac eval 15m |
1,131 |
707 |
$21K |
| 99402 |
|
405 |
364 |
$21K |
| 99310 |
Prolong nursin fac eval 15m |
1,180 |
532 |
$20K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,197 |
1,986 |
$20K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
556 |
269 |
$20K |
| 80053 |
Comprehensive metabolic panel |
2,290 |
2,075 |
$17K |
| 99233 |
Prolong inpt eval add15 m |
335 |
157 |
$14K |
| 95115 |
|
1,391 |
722 |
$13K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
465 |
414 |
$13K |
| 87276 |
|
1,061 |
988 |
$13K |
| 90697 |
|
864 |
818 |
$12K |
| 90671 |
|
891 |
832 |
$10K |
| 99205 |
Prolong outpt/office vis |
131 |
101 |
$10K |
| 90734 |
|
871 |
783 |
$10K |
| 81001 |
|
2,919 |
2,597 |
$9K |
| 92567 |
|
911 |
730 |
$8K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,796 |
1,590 |
$7K |
| 86403 |
|
496 |
457 |
$6K |
| 87275 |
|
534 |
496 |
$6K |
| 0001A |
|
216 |
199 |
$6K |
| 0002A |
|
198 |
191 |
$6K |
| 71046 |
Radiologic examination, chest; 2 views |
426 |
385 |
$6K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
24 |
19 |
$6K |
| 90723 |
|
449 |
430 |
$5K |
| 73110 |
|
467 |
156 |
$5K |
| 54150 |
|
28 |
27 |
$5K |
| 90715 |
|
457 |
411 |
$5K |
| 86703 |
|
331 |
301 |
$5K |
| 90696 |
|
390 |
366 |
$4K |
| 87400 |
|
799 |
586 |
$3K |
| 73630 |
|
213 |
117 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
1,498 |
1,343 |
$3K |
| 87280 |
|
286 |
271 |
$3K |
| 93971 |
|
203 |
160 |
$3K |
| 92557 |
|
221 |
160 |
$3K |
| 87420 |
|
251 |
232 |
$3K |
| 73562 |
|
237 |
116 |
$3K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
17 |
15 |
$3K |
| 90619 |
|
155 |
147 |
$3K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
379 |
365 |
$2K |
| 73030 |
|
150 |
101 |
$2K |
| 86140 |
|
605 |
481 |
$2K |
| 80061 |
Lipid panel |
926 |
917 |
$2K |
| 99221 |
|
83 |
60 |
$2K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
50 |
37 |
$2K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
888 |
754 |
$2K |
| 85651 |
|
727 |
580 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
115 |
87 |
$2K |
| 52332 |
|
16 |
12 |
$2K |
| 95886 |
|
29 |
25 |
$1K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
373 |
343 |
$1K |
| 90649 |
|
141 |
128 |
$1K |
| 73564 |
|
90 |
42 |
$1K |
| 82948 |
|
316 |
288 |
$1K |
| 90651 |
|
91 |
87 |
$1K |
| 73502 |
|
98 |
92 |
$1K |
| 90685 |
|
106 |
103 |
$1K |
| 86701 |
|
97 |
86 |
$1K |
| 99318 |
|
76 |
53 |
$999.36 |
| 95909 |
|
23 |
12 |
$993.59 |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
77 |
31 |
$974.43 |
| 73610 |
|
92 |
26 |
$883.70 |
| 92555 |
|
106 |
91 |
$870.58 |
| 99219 |
|
14 |
14 |
$761.31 |
| 93880 |
|
43 |
38 |
$739.99 |
| 99381 |
|
12 |
12 |
$732.12 |
| 90648 |
|
78 |
78 |
$726.56 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
159 |
147 |
$726.42 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
527 |
523 |
$702.38 |
| 90681 |
|
52 |
50 |
$630.72 |
| 72110 |
|
19 |
14 |
$591.37 |
| 99215 |
Prolong outpt/office vis |
15 |
13 |
$571.65 |
| 84443 |
Thyroid stimulating hormone (TSH) |
496 |
488 |
$529.87 |
| 73130 |
|
34 |
14 |
$500.00 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
55 |
52 |
$417.05 |
| 99217 |
|
17 |
13 |
$371.27 |
| 80055 |
|
12 |
12 |
$365.20 |
| 90707 |
|
28 |
26 |
$341.64 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
163 |
156 |
$333.28 |
| 90714 |
|
27 |
26 |
$315.36 |
| 90658 |
|
23 |
23 |
$298.83 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
421 |
387 |
$251.91 |
| 99401 |
|
15 |
12 |
$247.50 |
| 84439 |
|
108 |
107 |
$239.55 |
| 74420 |
|
20 |
12 |
$208.90 |
| 83655 |
|
14 |
14 |
$204.64 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
448 |
405 |
$192.36 |
| 99442 |
|
37 |
28 |
$190.00 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,451 |
1,337 |
$151.38 |
| 85018 |
|
70 |
56 |
$141.96 |
| 85014 |
|
70 |
56 |
$141.96 |
| 81003 |
|
70 |
57 |
$128.32 |
| J1020 |
Injection, methylprednisolone acetate, 20 mg |
36 |
35 |
$124.44 |
| G0008 |
Administration of influenza virus vaccine |
430 |
421 |
$116.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
14 |
13 |
$115.30 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
15 |
14 |
$104.16 |
| 87081 |
|
13 |
12 |
$75.76 |
| 81025 |
|
113 |
69 |
$67.53 |
| 82465 |
|
18 |
12 |
$56.48 |
| 0003A |
|
63 |
58 |
$38.47 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
40 |
39 |
$27.63 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
105 |
100 |
$14.19 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
58 |
53 |
$13.33 |
| 99441 |
|
59 |
55 |
$5.75 |
| 90662 |
|
208 |
206 |
$2.34 |
| 91300 |
|
16 |
15 |
$0.02 |
| 1036F |
|
1,751 |
1,618 |
$0.00 |
| 1101F |
|
280 |
256 |
$0.00 |
| 1000F |
|
2,485 |
2,272 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
882 |
795 |
$0.00 |
| 3074F |
|
655 |
598 |
$0.00 |
| 1125F |
|
79 |
76 |
$0.00 |
| 1220F |
|
72 |
70 |
$0.00 |
| 3008F |
|
166 |
149 |
$0.00 |
| 3079F |
|
14 |
14 |
$0.00 |
| 3075F |
|
14 |
12 |
$0.00 |
| 1159F |
|
2,363 |
2,181 |
$0.00 |
| 1160F |
|
2,682 |
2,446 |
$0.00 |
| 3288F |
|
2,227 |
2,023 |
$0.00 |
| 3078F |
|
735 |
673 |
$0.00 |
| 85007 |
|
51 |
49 |
$0.00 |
| 99001 |
|
99 |
86 |
$0.00 |
| 3725F |
|
41 |
38 |
$0.00 |
| 0518F |
|
14 |
13 |
$0.00 |
| 3077F |
|
15 |
13 |
$0.00 |
| 3015F |
|
56 |
51 |
$0.00 |
| Q2038 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) |
92 |
92 |
$0.00 |